                         SEQUENCE LISTING

<110>  Institute for Systems Biology
 
<120>  SINGLE CHAIN TRIMER MHC CLASS II NUCLEIC ACIDS AND PROTEINS AND 
       METHODS OF USE

<130>  9929-104166-02

<150>  US 62/978,120
<151>  2020-02-18

<160>  60    

<170>  PatentIn version 3.5

<210>  1
<211>  1377
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SCT-Z design nucleic acid

<400>  1
atggtgtgtc tgaagctgcc cggaggcagc tgcatgacag ccctgacagt gaccctgatg       60

gtgctgagct ctcctcttgc tcttgcttca gcattatcag aaggagccac cccacaagat      120

ttaaacacca tgctaggtgg aggaggttct ctagtgccac ggggctctgg aggtggtgga      180

agcggcgata ccagacctag atttctgtgg cagctgaaat ttgagtgcca cttctttaat      240

ggcaccgaga gagtgagact gctggagaga tgcatctata atcaggaaga aagcgtgaga      300

tttgatagcg atgtgggaga atatagagct gtgaccgaac tgggaagacc cgatgccgag      360

tattggaaca gccagaagga tctgctggaa cagagaagag ctgccgtgga tacatactgt      420

agacataatt acggcgtggg agaaagcttt acagtgcaga gaagagtgga acctaaagtg      480

acagtgtacc ctagcaagac acagcccctg cagcatcaca atctgctggt gtgtagcgtg      540

agcggattct atcctggaag catcgaagtg agatggttta gaaacggcca ggaagagaag      600

gctggagtgg tgagcacagg actgatccag aatggagatt ggacatttca gacactggtg      660

atgctggaaa cagtgcctag aagcggcgag gtgtatacat gtcaggtgga acatccaagc      720

gtgacaagcc cactgacagt ggaatggaga gctagatctg aatctgcaca gagcaagggt      780

ggcggtggga gtggtggtgg cggaatcaag gaagaacacg tgattattca ggctgagttc      840

tatctgaacc ctgaccagag cggagagttt atgtttgact ttgacggcga cgaaattttt      900

cacgtggaca tggctaagaa ggagacagtg tggagactgg aggagtttgg aagatttgct      960

agctttgaag ctcagggagc tctggctaat atcgctgtgg ataaggccaa tctggagatt     1020

atgaccaaga ggagcaacta cacacctatc accaacgtgc ctcctgaagt gacagtgctg     1080

acaaattctc ctgtggagct gagagaacct aatgtgctga tctgcttcat cgataagttc     1140

accccaccag tggttaatgt gacatggctg aggaatggca agccagtgac aacaggagtg     1200

tctgaaacag tgtttctgcc tagagaagac cacctgttca gaaagttcca ctatctgcct     1260

ttcctgccct ctacagagga tgtgtatgat tgcagagtgg aacattgggg cctggatgag     1320

cctctgctga aacactggga gtttgatgct ccttctcctc tgcctgagac aacagaa        1377


<210>  2
<211>  459
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SCT-Z design amino acid sequence

<400>  2

Met Val Cys Leu Lys Leu Pro Gly Gly Ser Cys Met Thr Ala Leu Thr 
1               5                   10                  15      


Val Thr Leu Met Val Leu Ser Ser Pro Leu Ala Leu Ala Ser Ala Leu 
            20                  25                  30          


Ser Glu Gly Ala Thr Pro Gln Asp Leu Asn Thr Met Leu Gly Gly Gly 
        35                  40                  45              


Gly Ser Leu Val Pro Arg Gly Ser Gly Gly Gly Gly Ser Gly Asp Thr 
    50                  55                  60                  


Arg Pro Arg Phe Leu Trp Gln Leu Lys Phe Glu Cys His Phe Phe Asn 
65                  70                  75                  80  


Gly Thr Glu Arg Val Arg Leu Leu Glu Arg Cys Ile Tyr Asn Gln Glu 
                85                  90                  95      


Glu Ser Val Arg Phe Asp Ser Asp Val Gly Glu Tyr Arg Ala Val Thr 
            100                 105                 110         


Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln Lys Asp Leu 
        115                 120                 125             


Leu Glu Gln Arg Arg Ala Ala Val Asp Thr Tyr Cys Arg His Asn Tyr 
    130                 135                 140                 


Gly Val Gly Glu Ser Phe Thr Val Gln Arg Arg Val Glu Pro Lys Val 
145                 150                 155                 160 


Thr Val Tyr Pro Ser Lys Thr Gln Pro Leu Gln His His Asn Leu Leu 
                165                 170                 175     


Val Cys Ser Val Ser Gly Phe Tyr Pro Gly Ser Ile Glu Val Arg Trp 
            180                 185                 190         


Phe Arg Asn Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu 
        195                 200                 205             


Ile Gln Asn Gly Asp Trp Thr Phe Gln Thr Leu Val Met Leu Glu Thr 
    210                 215                 220                 


Val Pro Arg Ser Gly Glu Val Tyr Thr Cys Gln Val Glu His Pro Ser 
225                 230                 235                 240 


Val Thr Ser Pro Leu Thr Val Glu Trp Arg Ala Arg Ser Glu Ser Ala 
                245                 250                 255     


Gln Ser Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ile Lys Glu Glu 
            260                 265                 270         


His Val Ile Ile Gln Ala Glu Phe Tyr Leu Asn Pro Asp Gln Ser Gly 
        275                 280                 285             


Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe His Val Asp Met 
    290                 295                 300                 


Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe Gly Arg Phe Ala 
305                 310                 315                 320 


Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val Asp Lys Ala 
                325                 330                 335     


Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro Ile Thr Asn 
            340                 345                 350         


Val Pro Pro Glu Val Thr Val Leu Thr Asn Ser Pro Val Glu Leu Arg 
        355                 360                 365             


Glu Pro Asn Val Leu Ile Cys Phe Ile Asp Lys Phe Thr Pro Pro Val 
    370                 375                 380                 


Val Asn Val Thr Trp Leu Arg Asn Gly Lys Pro Val Thr Thr Gly Val 
385                 390                 395                 400 


Ser Glu Thr Val Phe Leu Pro Arg Glu Asp His Leu Phe Arg Lys Phe 
                405                 410                 415     


His Tyr Leu Pro Phe Leu Pro Ser Thr Glu Asp Val Tyr Asp Cys Arg 
            420                 425                 430         


Val Glu His Trp Gly Leu Asp Glu Pro Leu Leu Lys His Trp Glu Phe 
        435                 440                 445             


Asp Ala Pro Ser Pro Leu Pro Glu Thr Thr Glu 
    450                 455                 


<210>  3
<211>  1450
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SCT-T design nucleic acid sequence

<400>  3
atggctatta gtggagtgcc cgtgctgggc ttcttcatca tcgccgtgct gatgagcgcc       60

caggagagct gggccatcaa ggaagaacac gtgattattc aggctgagtt ctatctgaac      120

cctgaccaga gcggagagtt tatgtttgac tttgacggcg acgaaatttt tcacgtggac      180

atggctaaga aggagacagt gtggagactg gaggagtttg gaagatttgc tagctttgaa      240

gctcagggag ctctggctaa tatcgctgtg gataaggcca atctggagat tatgaccaag      300

aggagcaact acacacctat caccaacgtg cctcctgaag tgacagtgct gacaaattct      360

cctgtggagc tgagagaacc taatgtgctg atctgcttca tcgataagtt caccccacca      420

gtggttaatg tgacatggct gaggaatggc aagccagtga caacaggagt gtctgaaaca      480

gtgtttctgc ctagagaaga ccacctgttc agaaagttcc actatctgcc tttcctgccc      540

tctacagagg atgtgtatga ttgcagagtg gaacattggg gcctggatga gcctctgctg      600

aaacactggg agtttgatgc tccttctcct ctgcctgaga caacagaagg tggcggtgga      660

tctggtggcg gagggtctca gcagggaaga ctggataagc tgacagtgac tagccagaac      720

ctgcagctgg aaaacctgag gatgaagctg cctaaacctc catcagcatt atcagaagga      780

gccaccccac aagatttaaa caccatgcta ggtggaggaa gttcaggagg tggtggaagc      840

ggtggtggcg ggtctggcga taccagacct agatttctgt ggcagctgaa atttgagtgc      900

cacttcttta atggcaccga gagagtgaga ctgctggaga gatgcatcta taatcaggaa      960

gaaagcgtga gatttgatag cgatgtggga gaatatagag ctgtgaccga actgggaaga     1020

cccgatgccg agtattggaa cagccagaag gatctgctgg aacagagaag agctgccgtg     1080

gatacatact gtagacataa ttacggcgtg ggagaaagct ttacagtgca gagaagagtg     1140

gaacctaaag tgacagtgta ccctagcaag acacagcccc tgcagcatca caatctgctg     1200

gtgtgtagcg tgagcggatt ctatcctgga agcatcgaag tgagatggtt tagaaacggc     1260

caggaagaga aggctggagt ggtgagcaca ggactgatcc agaatggaga ttggacattt     1320

cagacactgg tgatgctgga aacagtgcct agaagcggcg aggtgtatac atgtcaggtg     1380

gaacatccaa gcgtgacaag cccactgaca gtggaatgga gagctagatc tgaatctgca     1440

cagagcaaga                                                            1450


<210>  4
<211>  483
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SCT-T design amino acid sequence

<400>  4

Met Ala Ile Ser Gly Val Pro Val Leu Gly Phe Phe Ile Ile Ala Val 
1               5                   10                  15      


Leu Met Ser Ala Gln Glu Ser Trp Ala Ile Lys Glu Glu His Val Ile 
            20                  25                  30          


Ile Gln Ala Glu Phe Tyr Leu Asn Pro Asp Gln Ser Gly Glu Phe Met 
        35                  40                  45              


Phe Asp Phe Asp Gly Asp Glu Ile Phe His Val Asp Met Ala Lys Lys 
    50                  55                  60                  


Glu Thr Val Trp Arg Leu Glu Glu Phe Gly Arg Phe Ala Ser Phe Glu 
65                  70                  75                  80  


Ala Gln Gly Ala Leu Ala Asn Ile Ala Val Asp Lys Ala Asn Leu Glu 
                85                  90                  95      


Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro Ile Thr Asn Val Pro Pro 
            100                 105                 110         


Glu Val Thr Val Leu Thr Asn Ser Pro Val Glu Leu Arg Glu Pro Asn 
        115                 120                 125             


Val Leu Ile Cys Phe Ile Asp Lys Phe Thr Pro Pro Val Val Asn Val 
    130                 135                 140                 


Thr Trp Leu Arg Asn Gly Lys Pro Val Thr Thr Gly Val Ser Glu Thr 
145                 150                 155                 160 


Val Phe Leu Pro Arg Glu Asp His Leu Phe Arg Lys Phe His Tyr Leu 
                165                 170                 175     


Pro Phe Leu Pro Ser Thr Glu Asp Val Tyr Asp Cys Arg Val Glu His 
            180                 185                 190         


Trp Gly Leu Asp Glu Pro Leu Leu Lys His Trp Glu Phe Asp Ala Pro 
        195                 200                 205             


Ser Pro Leu Pro Glu Thr Thr Glu Gly Gly Gly Gly Ser Gly Gly Gly 
    210                 215                 220                 


Gly Ser Gln Gln Gly Arg Leu Asp Lys Leu Thr Val Thr Ser Gln Asn 
225                 230                 235                 240 


Leu Gln Leu Glu Asn Leu Arg Met Lys Leu Pro Lys Pro Pro Ser Ala 
                245                 250                 255     


Leu Ser Glu Gly Ala Thr Pro Gln Asp Leu Asn Thr Met Leu Gly Gly 
            260                 265                 270         


Gly Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Asp Thr 
        275                 280                 285             


Arg Pro Arg Phe Leu Trp Gln Leu Lys Phe Glu Cys His Phe Phe Asn 
    290                 295                 300                 


Gly Thr Glu Arg Val Arg Leu Leu Glu Arg Cys Ile Tyr Asn Gln Glu 
305                 310                 315                 320 


Glu Ser Val Arg Phe Asp Ser Asp Val Gly Glu Tyr Arg Ala Val Thr 
                325                 330                 335     


Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln Lys Asp Leu 
            340                 345                 350         


Leu Glu Gln Arg Arg Ala Ala Val Asp Thr Tyr Cys Arg His Asn Tyr 
        355                 360                 365             


Gly Val Gly Glu Ser Phe Thr Val Gln Arg Arg Val Glu Pro Lys Val 
    370                 375                 380                 


Thr Val Tyr Pro Ser Lys Thr Gln Pro Leu Gln His His Asn Leu Leu 
385                 390                 395                 400 


Val Cys Ser Val Ser Gly Phe Tyr Pro Gly Ser Ile Glu Val Arg Trp 
                405                 410                 415     


Phe Arg Asn Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu 
            420                 425                 430         


Ile Gln Asn Gly Asp Trp Thr Phe Gln Thr Leu Val Met Leu Glu Thr 
        435                 440                 445             


Val Pro Arg Ser Gly Glu Val Tyr Thr Cys Gln Val Glu His Pro Ser 
    450                 455                 460                 


Val Thr Ser Pro Leu Thr Val Glu Trp Arg Ala Arg Ser Glu Ser Ala 
465                 470                 475                 480 


Gln Ser Lys 
            


<210>  5
<211>  57
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SCT-Z design invariant region portion

<400>  5
atcaaggaag aacacgtgat tattcaggct gagttctatc tgaaccctga ccagagc          57


<210>  6
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SCT-Z design invariant region portion

<400>  6

Ile Lys Glu Glu His Val Ile Ile Gln Ala Glu Phe Tyr Leu Asn Pro 
1               5                   10                  15      


Asp Gln Ser 
            


<210>  7
<211>  62
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SCT-T design invariant chain, peptide, and linker portion

<400>  7

Gly Gly Ser Gln Gln Gly Arg Leu Asp Lys Leu Thr Val Thr Ser Gln 
1               5                   10                  15      


Asn Leu Gln Leu Glu Asn Leu Arg Met Lys Leu Pro Lys Pro Pro Ser 
            20                  25                  30          


Ala Leu Ser Glu Gly Ala Thr Pro Gln Asp Leu Asn Thr Met Leu Gly 
        35                  40                  45              


Gly Gly Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
    50                  55                  60          


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  WT1 peptide

<400>  8

Arg Met Phe Pro Asn Ala Pro Tyr Leu 
1               5                   


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza peptide

<400>  9

Pro Lys Tyr Val Lys Gln Asn Thr Leu Lys Leu Ala Thr 
1               5                   10              


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MART-1 peptide

<400>  10

Glu Leu Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Biotin ligase site

<400>  11

Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
1               5                   10                  15  


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence

<400>  12

Gly Gly Gly Gly Ser Leu Val Pro Arg Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15      


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence

<400>  13

Gly Gly Gly Gly Ser Gly Gly Gly 
1               5               


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence

<400>  14

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10  


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence

<400>  15

Gly Gly Gly Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence

<400>  16

Thr Arg Gly Gly Ala Ser Gly Gly Gly 
1               5                   


<210>  17
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SCT-T design invariant region

<400>  17

Gln Gln Gly Arg Leu Asp Lys Leu Thr Val Thr Ser Gln Asn Leu Gln 
1               5                   10                  15      


Leu Glu Asn Leu Arg Met Lys Leu Pro Lys Pro Pro 
            20                  25              


<210>  18
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Placeholder peptide

<400>  18

Ser Ala Leu Ser Glu Gly Ala Thr Pro Gln Asp Leu Asn Thr Met Leu 
1               5                   10                  15      


<210>  19
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide antigen

<400>  19

Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val Asp Lys 
1               5                   10                  15      


Ala 
    


<210>  20
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide antigen

<400>  20

Arg Phe Tyr Lys Thr Leu Arg Ala Glu Gln Ala Ser Gln 
1               5                   10              


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide antigen

<400>  21

Ser Met Arg Tyr Gln Ser Leu Ile Pro Arg Leu Val Glu Phe Phe 
1               5                   10                  15  


<210>  22
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide antigen

<400>  22

Val Gly Ser Asp Trp Arg Phe Leu Arg Gly Tyr His Gln Tyr Ala 
1               5                   10                  15  


<210>  23
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide antigen

<400>  23

Ala Pro Ile Tyr Asn Val Leu Pro Thr Thr Ser Leu Val Leu Gly Lys 
1               5                   10                  15      


Asn Gln Thr Leu 
            20  


<210>  24
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonulceotide primer

<400>  24
agcaagagca agaggag                                                      17


<210>  25
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer

<400>  25
ggtggaggag gttctc                                                       16


<210>  26
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 spike protein peptide

<400>  26

Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr 
1               5                   10                  15  


<210>  27
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  27

Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu 
1               5                   10                  15  


<210>  28
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  28

Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu 
1               5                   10                  15  


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  29

Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr 
1               5                   10                  15  


<210>  30
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  30

Phe Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser 
1               5                   10                  15  


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  31

Asn Leu Leu Leu Gln Tyr Gly Ser Phe Cys Thr Gln Leu Asn Arg 
1               5                   10                  15  


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  32

Thr Gln Leu Asn Arg Ala Leu Thr Gly Ile Ala Val Glu Gln Asp 
1               5                   10                  15  


<210>  33
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  33

Cys Ala Gln Lys Phe Asn Gly Leu Thr Val Leu Pro Pro Leu Leu 
1               5                   10                  15  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  34

Thr Asp Glu Met Ile Ala Gln Tyr Thr Ser Ala Leu Leu Ala Gly 
1               5                   10                  15  


<210>  35
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  35

Trp Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile Pro Phe Ala Met 
1               5                   10                  15  


<210>  36
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  36

Ile Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly 
1               5                   10                  15  


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  37

Thr Leu Val Lys Gln Leu Ser Ser Asn Phe Gly Ala Ile Ser Ser 
1               5                   10                  15  


<210>  38
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  38

Val Gln Ile Asp Arg Leu Ile Thr Gly Arg Leu Gln Ser Leu Gln 
1               5                   10                  15  


<210>  39
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  39

Leu Ile Thr Gly Arg Leu Gln Ser Leu Gln Thr Tyr Val Thr Gln 
1               5                   10                  15  


<210>  40
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  40

Leu Ala Ile Leu Thr Ala Leu Arg Leu Cys Ala Tyr Cys Cys Asn 
1               5                   10                  15  


<210>  41
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  41

Ser Trp Phe Thr Ala Leu Thr Gln His Gly Lys Glu Asp Leu Lys 
1               5                   10                  15  


<210>  42
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  42

Lys Asp Gly Ile Ile Trp Val Ala Thr Glu Gly Ala Leu Asn Thr 
1               5                   10                  15  


<210>  43
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  43

Ala Ile Val Leu Gln Leu Pro Gln Gly Thr Thr Leu Pro Lys Gly 
1               5                   10                  15  


<210>  44
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  44

Gly Ala Val Ile Leu Arg Gly His Leu Arg Ile Ala Gly His His Leu 
1               5                   10                  15      


Gly Arg 
        


<210>  45
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SARS-CoV-2 peptide

<400>  45

Pro Lys Glu Ile Thr Val Ala Thr Ser Arg Thr Leu Ser Tyr Tyr Lys 
1               5                   10                  15      


Leu 
    


<210>  46
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  46

Gly Pro Leu Lys Ala Glu Ile Ala Gln Arg Leu Glu 
1               5                   10          


<210>  47
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  47

Asn Phe Trp Arg Gly Glu Asn Gly Arg Lys Thr Arg 
1               5                   10          


<210>  48
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  48

Asp Thr Ile Ile Phe Glu Ala Asn Gly Asn Leu Ile Ala 
1               5                   10              


<210>  49
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  49

Glu Ile Ile Arg Met Met Glu Ser Ala Arg Pro Glu Asp 
1               5                   10              


<210>  50
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  50

Glu Leu Leu Val Leu Leu Glu Asn Glu Arg Thr Leu Asp 
1               5                   10              


<210>  51
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  51

Gly Pro Leu Lys Ala Glu Ile Ala Gln Arg Leu Glu Asp 
1               5                   10              


<210>  52
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Influenza A peptide

<400>  52

Gly Gln Ile Ser Ile Gln Pro Thr Phe Ser Val Gln Arg Asn 
1               5                   10                  


<210>  53
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Bacillus anthracis peptide

<400>  53

Ala Pro Ile Tyr Asn Val Leu Pro Thr Thr Ser Leu Val Leu Gly Lys 
1               5                   10                  15      


Asn Gln Thr Leu 
            20  


<210>  54
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Clostridium peptide

<400>  54

Glu Leu Ile His Val Leu His Gly Leu Tyr Gly Met Gln 
1               5                   10              


<210>  55
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Clostridium peptide

<400>  55

Glu Val Tyr Lys Leu Val Lys Ala Lys Trp Leu Gly Thr 
1               5                   10              


<210>  56
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIV peptide

<400>  56

Pro Glu Val Ile Pro Met Phe Ser Ala Leu Ser Glu Gly Ala Thr Pro 
1               5                   10                  15      


<210>  57
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Vaccinia virus peptide

<400>  57

Ser Met Arg Tyr Gln Ser Leu Ile Pro Arg Leu Val Glu Phe Phe 
1               5                   10                  15  


<210>  58
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human IDH1 peptide

<400>  58

Gly Trp Val Lys Pro Ile Ile Ile Gly His His Ala Tyr Gly Asp Gln 
1               5                   10                  15      


Tyr Arg Ala Thr 
            20  


<210>  59
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human HLA class II antigen gamma chain peptide

<400>  59

Lys Met Arg Met Ala Thr Pro Leu Leu Met Gln Ala Leu Pro Met 
1               5                   10                  15  


<210>  60
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human collagen alpha-1 (II) chain peptide

<400>  60

Gly Ile Ala Gly Phe Ala Gly Glu Gln Gly Pro Lys Gly Glu Pro 
1               5                   10                  15  


